Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Concentra's Buy Offer May Jeopardize Jounce's Merger with Redx
BioSpace
Wed, 03/15/23 - 11:29 am
Jounce Therapeutics
Redx
Concerta
M&A
In Pfizer-Seagen review, FTC has chance to set new pharma precedent
BioPharma Dive
Tue, 03/14/23 - 06:28 pm
FTC
Pfizer
Seagen
M&A
antitrust
anticompetitive practices
Pfizer CEO points to IRA as a factor that made Seagen an attractive target
Endpoints
Tue, 03/14/23 - 11:00 am
Pfizer
Seagen
M&A
Inflation Reduction Act
Illumina Responds to Icahn Partners' Nomination of Directors
BioSpace
Tue, 03/14/23 - 10:57 am
Illumina
Carl Icahn
M&A
Grail
Pfizer to buy Seagen in $43B cancer drug deal
BioPharma Dive
Mon, 03/13/23 - 10:57 am
Pfizer
Seagen
M&A
lymphoma
Adcetris
Carl Icahn takes proxy fight to Illumina: report
Endpoints
Mon, 03/13/23 - 10:12 am
Illumina
Grail
M&A
Carl Icahn
Sanofi throws down $2.9B to acquire diabetes partner Provention Bio
Fierce Pharma
Mon, 03/13/23 - 10:08 am
Sanofi
Provention Bio
M&A
diabetes
Pfizer Is Targeting an Acquisition That Could Be a Game Changer for Its Business
Motley Fool
Thu, 03/9/23 - 11:28 am
Pfizer
Seagen
M&A
Adaptimmune absorbs TCR² to extend cash runway and broaden T-cell pipeline
Fierce Biotech
Mon, 03/6/23 - 11:11 am
Adaptimmune Therapeutics
TCR2 Therapeutics
M&A
Bristol Myers dodges one $6.4B Celgene buyout CVR suit, but the battle is far from over
Fierce Pharma
Thu, 03/2/23 - 10:45 pm
Bristol Myers Squibb
Breyanzi
Celgene
legal
M&A
CVRs
Latest biotech-on-biotech merger sees aimless Adamis snapped up by DMK
Fierce Biotech
Tue, 02/28/23 - 10:24 am
Adamis Pharmaceuticals
DMK Pharmaceuticals
M&A
COVID-19
Medtech’s M&A Scene Stays Hot with Olympus Deal
Medical Devices and Diagnostics Industry
Mon, 02/27/23 - 07:08 pm
devices
Medtech
M&A
Olympus
Taewoong Medical
Seagen has a New Suitor as Pfizer Talks Begin
BioSpace
Mon, 02/27/23 - 10:21 am
Seagen
Pfizer
M&A
Jounce Slashes 57% of Staff, Drops Assets in Stock Merger with Redx
BioSpace
Fri, 02/24/23 - 09:18 am
Jounce Therapeutics
Redx
M&A
layoffs
Conditions are ripe for reverse mergers
EP Vantage
Fri, 02/24/23 - 08:48 am
M&A
reverse merger
Redx
Jounce Therapeutics
Pherecydes
Erytech
Flame Biosciences
Leap Therapeutics
Elicio Therapeutics
Angion
US deal watchdog's bark could be worse than its bite
EP Vantage
Thu, 02/23/23 - 09:58 am
M&A
FTC
Seagen mum on Merck buyout rumors as it bats for blockbuster with Adcetris
BioSpace
Thu, 02/16/23 - 11:27 am
Seagen
earnings
Merck
M&A
Adcetris
Amgen bond offering to help fund Horizon Therapeutics acquisition
Seeking Alpha
Thu, 02/16/23 - 11:26 am
Amgen
bond
M&A
Horizon Therapeutics
Biotech consolidation continues as Nasdaq-listed Erytech merges with phage therapy developer
Endpoints
Thu, 02/16/23 - 10:29 am
Erytech
NASDAQ
Pferecydes
M&A
Insulet pays Bigfoot Biomedical $25M for pump-based automated insulin delivery technology
Medtech Dive
Wed, 02/15/23 - 10:25 am
Medtech
M&A
Insulet
Bigfoot Biomedical
automated insulin delivery
diabetes
Pages
« first
‹ previous
…
19
20
21
22
23
24
25
26
27
…
next ›
last »